He has published >300 full papers and reviews in peer-reviewed international journals and has received several national and international prizes, including the Juvenile Diabetes Research Foundation (JDRF) Diabetes Care Research Award, 1998, the “2012 Albert Renold Prize Lecture for Outstanding Achievements in Research on the Islets of Langernhans” awarded by the European Association for the Study of Diabetes (EASD), Berlin, Germany, 10.2012 and the “2013 Rumbough Award for outstanding achievements in type 1 diabetes research”, awarded by the JDRF, New York, 12.2013. He is listed by the ISI Essential Science Indicators among the 1% most cited scientists in Clinical Medicine and Biology & Biochemistry, with an h-index of 65. Dr Eizirik coordinates the “BetaBat” international project, supported by the EC (http://betabat.ulb.ac.be/) and the “Beta Cell Gene Expression Bank”. He has served as Honorary (Scientific) Secretary of the EASD and as Deputy Editor of Diabetologia. D.L. Eizirik research focuses on the molecular mechanisms regulating insulitis and beta cell apoptosis in type 1 diabetes and on the search for novel approaches to prevent the progressive loss of beta cell mass in diabetes.